Company Filing History:
Years Active: 2012
Title: Kevin D Pfleger: Innovator in Molecular Detection Systems
Introduction
Kevin D Pfleger is a prominent inventor based in Nedlands, Australia. He has made significant contributions to the field of molecular detection, showcasing his innovative spirit through his patented technologies. His work is particularly focused on systems that enhance the detection of molecular associations, which has important implications in various scientific and medical applications.
Latest Patents
Kevin D Pfleger holds a patent for a "Detection system and uses therefor." This system is designed for the detection of molecular associations and comprises several key components. It includes a first agent with a first interacting group coupled to a first reporter component, a second agent with a second interacting group coupled to a second reporter component, and a third agent with a third interacting group. Additionally, the system features a modulator and a detector. The proximity of the first and second reporter components generates a detectable signal, while the modulator influences the association of the second interacting group with the third interacting group. This innovative approach allows for monitoring the association of the first and third agents through the generated signal.
Career Highlights
Kevin D Pfleger is associated with Dimerix Bioscience Pty Ltd, where he applies his expertise in molecular detection systems. His work at the company has positioned him as a key player in advancing technologies that can significantly impact research and development in the life sciences sector.
Collaborations
Throughout his career, Kevin has collaborated with notable colleagues, including Ruth Marie Seeber and Heng Boon See. These partnerships have fostered a collaborative environment that enhances innovation and drives forward the research initiatives at Dimerix Bioscience Pty Ltd.
Conclusion
Kevin D Pfleger's contributions to molecular detection systems exemplify the impact of innovative thinking in science and technology. His patent and work at Dimerix Bioscience Pty Ltd highlight his commitment to advancing the field and improving detection methodologies.